Erlotinib Completed Phase 1 Trials for Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity / Stage IV Squamous Cell Carcinoma of the Hypopharynx / Stage IV Basal Cell Carcinoma of the Lip / Recurrent Extrahepatic Bile Duct Cancer / Stage IV Non-Small Cell Lung Cancer / Recurrent Squamous Cell Carcinoma of the Larynx / Small Intestine Adenocarcinoma / Recurrent Lymphoepithelioma of the Nasopharynx / Stage IV Squamous Cell Carcinoma of the Nasopharynx / Recurrent Basal Cell Carcinoma of the Lip / Stage IV Adenoid Cystic Carcinoma of the Oral Cavity / Recurrent Colon Cancer / Adenocarcinoma of the Colon / Recurrent Mucoepidermoid Carcinoma of the Oral Cavity / Stage IV Esophageal Cancer / Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity / Tongue Cancer / Recurrent Inverted Papilloma of the Paranasal Sinus and Nasal Cavity / Recurrent Gallbladder Cancer / Stage IV Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity / Recurrent Adult Primary Liver Cancer / Recurrent Rectal Cancer / Stage IV Squamous Cell Carcinoma of the Oropharynx / Recurrent Metastatic Squamous Neck Cancer With Occult Primary / Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity / Metastatic Squamous Neck Cancer With Occult Primary / Stage IV Salivary Gland Cancer / Carcinoma of the Appendix / Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity / Stage IV Pancreatic Cancer / Metastatic Colon Cancer / Stage IV Verrucous Carcinoma of the Larynx / Small Intestine Lymphoma / Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity / Stage IV Squamous Cell Carcinoma of the Larynx / Recurrent Gastric Cancer / Recurrent Salivary Gland Cancer / Recurrent Pancreatic Cancer / Small Intestine Leiomyosarcoma / Stage IV Inverted Papilloma of the Paranasal Sinus and Nasal Cavity / Advanced Adult Primary Liver Cancer / Adenocarcinoma of the Rectum / Advanced Gastric Cancer / Stage IV Verrucous Carcinoma of the Oral Cavity / Unresectable Gallbladder Cancer / Stage IV Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity / Stage IV Anal Cancer / Recurrent Verrucous Carcinoma of the Larynx / Recurrent Squamous Cell Carcinoma of the Nasopharynx / Recurrent Small Intestine Cancer / Recurrent Anal Cancer / Recurrent Adenoid Cystic Carcinoma of the Oral Cavity / Stage IV Mucoepidermoid Carcinoma of the Oral Cavity / Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity / Recurrent Squamous Cell Carcinoma of the Hypopharynx / Non-Small Cell Lung Cancer Recurrent / Recurrent Esophageal Cancer / Stage IV Lymphoepithelioma of the Nasopharynx / Recurrent Lymphoepithelioma of the Oropharynx / Recurrent Verrucous Carcinoma of the Oral Cavity / Recurrent Squamous Cell Carcinoma of the Oropharynx / Gastrointestinal Stromal Tumors / Stage IV Lymphoepithelioma of the Oropharynx / Recurrent Gastrointestinal Carcinoid Tumor / Metastatic Gastrointestinal Carcinoid Tumor / Stage IV Rectal Cancer / Unresectable Extrahepatic Bile Duct Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00397384Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer